OMEROS CORPORATION OMER Income Statement

Omeros corporation (OMER)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenues [Abstract]
Product sales, net
-	-	-	-	-	-	-	-	-	-	-	17,151	12,257	-	11,289	10,004	7,246	6,657	3,244	3,125	238	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Grant revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	173	18	15	62	150	180	214	45	100	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product sales, net
23,537	33,417	29,856	26,753	21,779	22,017	4,608	1,655	1,588	-	21,658	-	0	12,905	11,289	10,004	7,419	6,675	3,259	3,187	388	180	214	45	100	169	196	140	1,095	1,583	1,417	1,526	1,496	1,143	987	1,155	1,239	254	497
Costs and expenses:
Cost of product sales
267	401	278	55	131	157	36	116	203	466	184	157	271	380	378	327	327	417	248	365	11	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research and development
28,911	40,587	23,746	19,108	26,255	25,446	26,862	19,412	18,140	15,387	14,835	13,137	12,240	12,542	12,492	10,231	15,434	14,897	13,264	10,900	9,318	11,750	11,772	12,407	12,017	10,186	9,420	9,564	7,127	9,354	7,764	7,558	7,246	8,895	5,321	4,077	5,425	5,316	6,120
Selling, general and administrative
18,036	16,133	16,933	16,928	14,632	14,888	13,152	12,744	10,934	12,028	11,749	15,796	12,471	11,840	10,457	10,375	11,110	9,401	9,048	7,889	8,989	8,405	5,574	4,855	3,767	3,885	4,210	3,736	3,988	3,715	2,736	2,212	2,322	2,095	1,830	2,027	2,264	2,428	2,011
Total costs and expenses
47,214	57,121	40,957	36,091	41,018	40,491	40,050	32,272	29,277	27,881	26,768	29,090	24,982	24,762	23,327	20,933	26,871	24,715	22,560	19,154	18,318	20,155	17,346	17,262	15,784	14,071	13,630	13,300	11,115	9,116	14,453	9,770	9,568	10,990	7,151	6,104	7,689	7,744	8,131
Loss from operations
-23,700	-23,722	-11,101	-9,338	-19,239	-18,452	-35,442	-30,617	-27,689	-14,126	-5,110	-11,939	-12,725	-11,857	-12,038	-10,929	-19,452	-18,040	-19,301	-15,967	-17,930	-19,975	-17,132	-17,217	-15,684	-13,902	-13,434	-13,160	-10,020	-7,533	-13,036	-8,244	-8,072	-9,847	-6,164	-4,949	-6,450	-7,490	-7,634
Other income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	576	2	2	6	8	14	6	12	11	9	14	17	108	21
Litigation settlement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-3,953	-	-	-	-	-	-	-	-
Interest expense
5,903	5,812	5,715	5,530	5,600	5,149	4,602	3,676	2,825	2,864	2,780	2,723	2,663	2,452	2,135	1,857	1,375	808	871	937	957	915	944	939	672	598	592	589	587	369	413	453	494	536	528	527	293	362	409
Other income
549	291	353	415	494	152	572	597	460	434	408	303	299	272	211	174	288	-	251	224	218	-	-251	165	-286	-	154	155	112	160	159	152	-341	171	171	171	184	189	218
Net loss
-29,031	-29,225	-16,463	-14,453	-24,345	-23,535	-39,472	-33,696	-30,054	-16,551	-7,482	-14,359	-15,089	-19,632	-13,962	-12,612	-20,539	-19,826	-19,921	-16,680	-18,669	-20,713	-18,327	-17,991	-16,642	-1,845	-13,870	-13,592	-10,489	-7,734	-13,276	-8,539	-8,895	-10,201	-6,512	-5,291	-6,542	-7,555	-7,804
Comprehensive loss
-29,031	-29,225	-16,463	-14,453	-24,345	-23,535	-39,472	-33,696	-30,054	-16,551	-7,482	-14,359	-15,089	-19,632	-13,962	-12,612	-20,539	-19,826	-19,921	-16,680	-18,669	-20,713	-18,327	-17,991	-16,642	-1,845	-13,870	-13,592	-10,489	-7,734	-13,276	-8,539	-8,895	-10,201	-6,512	-5,291	-6,542	-	-
Basic and diluted net loss per share (USD per share)
-0.53	-0.59	-0.33	-0.29	-0.50	-0.48	-0.81	-0.70	-0.62	-0.34	-0.16	-0.33	-0.34	-0.45	-0.34	-0.32	-0.54	-0.52	-0.53	-0.44	-0.51	-0.61	-0.54	-0.53	-0.54	-0.05	-0.46	-0.48	-0.40	-0.30	-0.51	-0.38	-0.40	-0.46	-0.29	-0.24	-0.30	-0.35	-0.36
Weighted-average shares used to compute basic and diluted net loss per share ( in shares)
54,299	50,622	49,373	49,084	49,014	49,014	48,647	48,384	48,284	48,029	46,262	44,037	43,828	43,231	41,058	39,178	38,317	37,987	37,923	37,846	36,483	34,101	34,005	33,933	30,897	30,289	29,844	28,199	25,908	25,886	25,834	22,466	22,434	22,378	22,246	22,167	22,056	21,487	21,381